Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache

Not Applicable

Withdrawn

• Conditions: Mental Disorders

• Registration Number: NCT00258791
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

The purpose of the study is to determine whether ibuprofen reduces post-ECT headache or reduces its severity.

Detailed Description

The aim of the study is to compare the severity of headache between patients who are receiving ibuprofen prior to ECT treatment with patients receiving placebo prior to ECT treatment.

Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally, blinded to patient, physician and treatment team.

Patients will be asked about their headache with a visual analogue scale (VAS) 2 hours prior to and within 2 hours after treatment, 2-month, 6- month and 1 year follow-up \[5\].

Study Timeline

• Study First Submitted: 2005-11-24
• Study First Submitted QC: 2005-11-25
• Study First Posted: 2005-11-28
• Study Start: 2012-01
• Primary Completion: 2012-05
• Study Completion: 2012-05
• Status Verified: 2012-09
• Last Update Submitted: 2012-09-21
• Last Update Posted: 2012-09-25

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients receiving ECT

Exclusion Criteria

• Pregnancy, contraindications to ibuprofen

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER